Because breast-fed infants are at less risk from certain chronic disea
ses that are immunologically mediated and because the immune system of
infants appears to be altered by breast-feeding, investigations have
been conducted to ascertain whether human milk contains immunomodulati
ng agents. In addition to certain peptide and nonpeptide hormones, gro
wth factors, other proteins and peptides, lipids and nucleotides, the
most represented group of immunomodulating agents so far discovered in
human milk is the family of the cytokines. The cytokines that have be
en to date measured in human milk are interleukin (IL)-1 beta, IL-6, I
L-10, granulocyte colony-stimulating factor, macrophage colony-stimula
ting factor, tumor necrosis factor alpha, transforming growth factor b
eta 2, inteferon-gamma, and the chemokines IL-8, growth-related peptid
e alpha, monocyte chemotactic protein 1 and the factor termed ''regula
ted upon activation, normal T cell expressed and secreted,'' more wide
ly known as RANTES. The spectrum, origins and physical distributions o
f these agents in human milk are under investigation. Certain cytokine
s including IL-6, IL-8, and macrophage colony-stimulating factor are p
roduced by mammary gland epithelial cells. There is also evidence that
some cytokines such as IL-6, IL-10 and tumor necrosis factor-alpha ar
e compartmentalized and thus protected from digestion in the recipient
. That may bear upon the possible in vivo function of those agents. Th
e in vivo role of the immunomodulating agents has not, however, been d
irectly demonstrated. The information will be critical to understandin
g how breast-feeding exerts long-term immunologic effects upon the rec
ipient infant.